Insider · CIK 0001869248
Benjamin T Dake
officer
Files at JBIO (Aerovate Therapeutics, Inc.). First filing Nov 27, 2023, latest Apr 19, 2024.
In brief
Benjamin T Dake files SEC Form 4 as officer at JBIO (Aerovate Therapeutics, Inc.). Since Nov 27, 2023, Benjamin T Dake has reported 0 open-market buys worth $0 and 8 open-market sells worth $2.2M, the latest filed on Apr 19, 2024.
A track record needs three past buys with six months of prices behind them; Benjamin T Dake has 0, so none is measured yet.
The newest scored trade: sold $153k of JBIO on Apr 17, 2024, filed Apr 19, 2024, scored 26 (weak), under a 10b5-1 plan.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 8
$0 bought, $2.2M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
JBIO: Aerovate Therapeutics, Inc.
JBIOOct 12, 2026 · close 14.00
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 26Weak | Aerovate Therapeutics, Inc. | $153k 6,853 shares | -84% | +135% from low-27% from high | |
| 25Weak | Aerovate Therapeutics, Inc. | $106k 3,325 shares | -72% | +221% from low0% from high | |
| 29Weak | Aerovate Therapeutics, Inc. | $310k 11,068 shares | -90% | +197% from low0% from high | |
| 25Weak | Aerovate Therapeutics, Inc. | $96k 3,432 shares | -73% | +181% from low-0% from high | |
| 39Weak | Aerovate Therapeutics, Inc. | $908k 35,057 shares | -96% | +175% from low-2% from high | |
| 26Weak | Aerovate Therapeutics, Inc. | $166k 10,283 shares | -89% | +69% from low-47% from high | |
| 20Weak | Aerovate Therapeutics, Inc. | $203k 12,517 shares | -91% | +67% from low-48% from high | |
| 20Weak | Aerovate Therapeutics, Inc. | $221k 14,372 shares | -135% | +60% from low-50% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Apr 17, 2024 | JBIO Aerovate Therapeutics, Inc. | 6,853 0.02% of outstanding | $162k | Apr 17, 2024 | $1.4M |
| Mar 18, 2024 | JBIO Aerovate Therapeutics, Inc. | 56,410 0.20% of outstanding | $1.5M | Mar 18, 2024 | none |
| Nov 22, 2023 | JBIO Aerovate Therapeutics, Inc. | 37,172 0.13% of outstanding | $539k | Nov 22, 2023 | $60k |
Transactions
The newest 50 of 52 rows this insider has filed.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 31, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Common Stock | +11,454 | $1.74 | $20k | 12,745 | Aug 2, 2024 |
| Aug 1, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Common Stock | +1,507 | $1.74 | $2,622 | 14,252 | Aug 2, 2024 |
| Jul 31, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -906 | $0.00 | $0 | 0 | Aug 2, 2024 |
| Jul 31, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -10,548 | $0.00 | $0 | 1,507 | Aug 2, 2024 |
| Aug 1, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -1,507 | $0.00 | $0 | 0 | Aug 2, 2024 |
| Apr 17, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +6,853 | $2.14 | $15k | 8,144 | Apr 19, 2024 |
| Apr 17, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -6,447 | $22.32 | $144k | 1,697 | Apr 19, 2024 |
| Apr 17, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -338 | $23.17 | $7,831 | 1,359 | Apr 19, 2024 |
| Apr 17, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -68 | $23.97 | $1,630 | 1,291 | Apr 19, 2024 |
| Apr 17, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -6,853 | $0.00 | $0 | 95,936 | Apr 19, 2024 |
| Apr 1, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +3,325 | $10.61 | $35k | 4,616 | Apr 3, 2024 |
| Apr 1, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -3,325 | $31.97 | $106k | 1,291 | Apr 3, 2024 |
| Apr 1, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -3,325 | $0.00 | $0 | 25,675 | Apr 3, 2024 |
| Mar 27, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +11,068 | $10.61 | $117k | 12,359 | Mar 28, 2024 |
| Mar 27, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -11,068 | $27.97 | $310k | 1,291 | Mar 28, 2024 |
| Mar 27, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -11,068 | $0.00 | $0 | 29,000 | Mar 28, 2024 |
| Mar 25, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +3,432 | $10.61 | $36k | 4,723 | Mar 27, 2024 |
| Mar 25, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -3,432 | $28.01 | $96k | 1,291 | Mar 27, 2024 |
| Mar 25, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -3,432 | $0.00 | $0 | 40,068 | Mar 27, 2024 |
| Mar 18, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +20,557 | $2.14 | $44k | 21,848 | Mar 20, 2024 |
| Mar 18, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +14,500 | $10.61 | $154k | 36,348 | Mar 20, 2024 |
| Mar 18, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -27,476 | $25.74 | $707k | 8,872 | Mar 20, 2024 |
| Mar 18, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -7,581 | $26.48 | $201k | 1,291 | Mar 20, 2024 |
| Mar 18, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -20,557 | $0.00 | $0 | 102,789 | Mar 20, 2024 |
| Mar 18, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -14,500 | $0.00 | $0 | 43,500 | Mar 20, 2024 |
| Jan 22, 2024 | JBIO Aerovate Therapeutics, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +66,586 | $0.00 | $0 | 66,586 | Jan 24, 2024 |
| Dec 6, 2023 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +2,411 | $1.74 | $4,195 | 3,702 | Dec 7, 2023 |
| Dec 6, 2023 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +7,872 | $2.14 | $17k | 11,574 | Dec 7, 2023 |
| Dec 6, 2023 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -10,283 | $16.11 | $166k | 1,291 | Dec 7, 2023 |
| Dec 6, 2023 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -905 | $0.00 | $0 | 906 | Dec 7, 2023 |
| Dec 6, 2023 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,506 | $0.00 | $0 | 12,055 | Dec 7, 2023 |
| Dec 6, 2023 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,019 | $0.00 | $0 | 16,294 | Dec 7, 2023 |
| Dec 6, 2023 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -6,853 | $0.00 | $0 | 123,346 | Dec 7, 2023 |
| Nov 27, 2023 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +2,413 | $1.74 | $4,199 | 3,704 | Nov 29, 2023 |
| Nov 27, 2023 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +10,104 | $2.14 | $22k | 13,808 | Nov 29, 2023 |
| Nov 27, 2023 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -12,517 | $16.24 | $203k | 1,291 | Nov 29, 2023 |
| Nov 27, 2023 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -906 | $0.00 | $0 | 1,811 | Nov 29, 2023 |
| Nov 27, 2023 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,507 | $0.00 | $0 | 13,561 | Nov 29, 2023 |
| Nov 27, 2023 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,018 | $0.00 | $0 | 17,313 | Nov 29, 2023 |
| Nov 27, 2023 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -9,086 | $0.00 | $0 | 130,199 | Nov 29, 2023 |
| Nov 22, 2023 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +2,412 | $1.74 | $4,197 | 3,703 | Nov 27, 2023 |
| Nov 22, 2023 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +6,970 | $2.14 | $15k | 10,673 | Nov 27, 2023 |
| Nov 22, 2023 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -9,382 | $15.17 | $142k | 1,291 | Nov 27, 2023 |
| Nov 24, 2023 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +4,990 | $2.14 | $11k | 6,281 | Nov 27, 2023 |
| Nov 24, 2023 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -4,920 | $15.74 | $77k | 1,361 | Nov 27, 2023 |
| Nov 24, 2023 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -70 | $16.07 | $1,125 | 1,291 | Nov 27, 2023 |
| Nov 22, 2023 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -905 | $0.00 | $0 | 2,717 | Nov 27, 2023 |
| Nov 22, 2023 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,507 | $0.00 | $0 | 15,068 | Nov 27, 2023 |
| Nov 22, 2023 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -648 | $0.00 | $0 | 18,702 | Nov 27, 2023 |
| Nov 22, 2023 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -6,322 | $0.00 | $0 | 143,904 | Nov 27, 2023 |
50 of 52 rows shown.
Questions about Benjamin T Dake
Answered from the filings on this page, as of the latest one.
Is Benjamin T Dake buying or selling?
Not in the last 12 months. Benjamin T Dake's latest open-market trade on SEC Form 4 was sold $153k of JBIO on Apr 17, 2024.
How did Benjamin T Dake's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Benjamin T Dake has 0.
Where does Benjamin T Dake file Form 4?
Benjamin T Dake has filed Form 4 at JBIO (Aerovate Therapeutics, Inc.) as SEE REMARKS. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.